VBI Vaccines (Delaware) Inc.

VBI Vaccines (Delaware) Inc., doing business as VBI Vaccines Inc., is a foreign-owned, for-profit corporate entity registered to receive federal awards from the U.S. government. It develops and manufactures vaccines for various infectious diseases.

VBI Vaccines Inc. holds multiple federal contract IDVs awarded by the Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), and other agencies. The CDC awarded VBI an indefinite delivery, indefinite quantity contract valued at up to $25.35 million to supply adult vaccines from July 2023 through June 2024. The contract covers 12 adult vaccines, including for hepatitis A/B, pneumococcal disease, tetanus/diphtheria, herpes zoster, measles/mumps/rubella, meningococcal disease, HPV, and varicella. These vaccines support CDC's immunization programs administered through state health departments. Additionally, VBI holds Federal Supply Schedule contracts with the VA to provide drugs, pharmaceuticals, and hematology-related products, with a $225,000 contract running through November 2027 and a separate $25,000 interim agreement expiring in November 2022. Through these IDVs, VBI can receive task orders from VA medical facilities to supply necessary medications and pharmaceutical supplies for treating veterans.